Capricor Therapeutics (CAPR) Other Non-Current Liabilities (2012 - 2014)

Capricor Therapeutics' Other Non-Current Liabilities history runs 3 years deep, the most recent figure standing at $11.3 million for Q1 2014.

• In Q1 2014, Other Non-Current Liabilities rose 2672.92% year-over-year to $11.3 million; the TTM figure through Mar 2014 stood at $11.3 million (up 2672.92% YoY), while the FY2013 annual figure was $4.0 million, changed N/A from the prior year.
• Other Non-Current Liabilities was $11.3 million for Q1 2014 at Capricor Therapeutics, up from $4.0 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $11.3 million in Q1 2014 to a low of $180850.0 in Q3 2012.
• Historically, Other Non-Current Liabilities has averaged $2.4 million across 3 years, with a median of $499993.0 in 2013.
• The sharpest annual moves came in 2013 and 2014: Other Non-Current Liabilities surged 168.3% in 2013, then surged 2672.92% in 2014.
• A 3-year view of Other Non-Current Liabilities shows it stood at $180850.0 in 2012, then surged by 2122.76% to $4.0 million in 2013, then surged by 182.02% to $11.3 million in 2014.
• The last three Other Non-Current Liabilities figures came in at $11.3 million (Q1 2014), $4.0 million (Q4 2013), and $499993.0 (Q3 2013), per Business Quant data.